Claessen N - Search Results

1

Levamisole suppresses activation and proliferation of human T cells by the induction of a p53-dependent DNA damage response.

Khan GH, Veltkamp F, Scheper M, Hoebe RA, Claessen N, Butter L, Bouts AHM, Florquin S, Guikema JEJ; LEARNS Consortium. Khan GH, et al. Among authors: claessen n. Eur J Immunol. 2023 Nov;53(11):e2350562. doi: 10.1002/eji.202350562. Epub 2023 Aug 31. Eur J Immunol. 2023. PMID: 37597325

2

Mercuric chloride-induced programmed cell death of a murine T cell hybridoma. I. Effect of the proto-oncogene Bcl-2.

Aten J, Prigent P, Poncet P, Blanpied C, Claessen N, Druet P, Hirsch F. Aten J, et al. Among authors: claessen n. Cell Immunol. 1995 Mar;161(1):98-106. doi: 10.1006/cimm.1995.1013. Cell Immunol. 1995. PMID: 7867088

3

Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia.

Florquin S, van den Berg JG, Olszyna DP, Claessen N, Opal SM, Weening JJ, van der Poll T. Florquin S, et al. Among authors: claessen n. Kidney Int. 2001 Jun;59(6):2054-61. doi: 10.1046/j.1523-1755.2001.00719.x. Kidney Int. 2001. PMID: 11380806 Free article.

4

Severe non-proliferative lupus nephritis with predominant sub-endothelial IgA deposits.

Florquin S, Roos A, Groothoff JW, Claessen N, van Gijlswijk-Janssen DJ, Aten J, Davin JC, Weening JJ. Florquin S, et al. Among authors: claessen n. Nephrol Dial Transplant. 2001 Jul;16(7):1479-82. doi: 10.1093/ndt/16.7.1479. Nephrol Dial Transplant. 2001. PMID: 11427645 No abstract available.

5

CD44 expression in IgA nephropathy.

Florquin S, Nunziata R, Claessen N, van den Berg FM, Pals ST, Weening JJ. Florquin S, et al. Among authors: claessen n. Am J Kidney Dis. 2002 Feb;39(2):407-14. doi: 10.1053/ajkd.2002.30563. Am J Kidney Dis. 2002. PMID: 11840384

6

Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection.

Roelofs JJ, Rowshani AT, van den Berg JG, Claessen N, Aten J, ten Berge IJ, Weening JJ, Florquin S. Roelofs JJ, et al. Among authors: claessen n. Kidney Int. 2003 Nov;64(5):1845-53. doi: 10.1046/j.1523-1755.2003.00261.x. Kidney Int. 2003. PMID: 14531820 Free article.

7

CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy.

Rouschop KM, Sewnath ME, Claessen N, Roelofs JJ, Hoedemaeker I, van der Neut R, Aten J, Pals ST, Weening JJ, Florquin S. Rouschop KM, et al. Among authors: claessen n. J Am Soc Nephrol. 2004 Mar;15(3):674-86. doi: 10.1097/01.asn.0000115703.30835.96. J Am Soc Nephrol. 2004. PMID: 14978169

8

Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution.

Stokman G, Leemans JC, Claessen N, Weening JJ, Florquin S. Stokman G, et al. Among authors: claessen n. J Am Soc Nephrol. 2005 Jun;16(6):1684-92. doi: 10.1681/ASN.2004080678. Epub 2005 Apr 20. J Am Soc Nephrol. 2005. PMID: 15829714

9

Protection against renal ischemia reperfusion injury by CD44 disruption.

Rouschop KM, Roelofs JJ, Claessen N, da Costa Martins P, Zwaginga JJ, Pals ST, Weening JJ, Florquin S. Rouschop KM, et al. Among authors: claessen n. J Am Soc Nephrol. 2005 Jul;16(7):2034-43. doi: 10.1681/ASN.2005010054. Epub 2005 May 18. J Am Soc Nephrol. 2005. PMID: 15901765

10

Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney.

Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S. Leemans JC, et al. Among authors: claessen n. J Clin Invest. 2005 Oct;115(10):2894-903. doi: 10.1172/JCI22832. J Clin Invest. 2005. PMID: 16167081 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page